From January 1, 2024 to March 31, 2024, the company has repurchased 615,633 shares, representing 0.54% for CNY 26.25 million. With this, the company has completed the repurchase of 858,316 shares, representing 0.75% for CNY 40 million under the buyback announced on October 31, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
37.81 CNY | +2.77% | +13.37% | -31.47% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-31.47% | 600M | |
+1.45% | 40.51B | |
-15.94% | 31.67B | |
+52.66% | 24.62B | |
-14.50% | 15.65B | |
-14.38% | 12.07B | |
-9.12% | 11.97B | |
-42.56% | 11.61B | |
+4.87% | 8.81B | |
-4.33% | 8.5B |
- Stock Market
- Equities
- 688293 Stock
- News Shanghai OPM Biosciences Co., Ltd.
- Tranche Update on Shanghai OPM Biosciences Co., Ltd.'s Equity Buyback Plan announced on October 31, 2023.